Literature DB >> 20674153

Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway.

Songgang Li1, Ping Dong, Jianwei Wang, Jie Zhang, Jun Gu, Xiangsong Wu, Wenguang Wu, Xiaozhou Fei, Zhiping Zhang, Yong Wang, Zhiwei Quan, Yingbin Liu.   

Abstract

In this study, the anticancer effect of icariin, a natural flavonol glycoside, against human hepatoma SMMC-7721 cells and the underlying mechanisms were investigated. Icariin triggered the mitochondrial/caspase apoptotic pathway indicated by enhanced Bax-to-Bcl-2 ratio, loss of mitochondrial membrane potential, cytochrome c release, and caspase cascade. Moreover, icariin induced a sustained activation of the phosphorylation of c-Jun N-terminal kinase (JNK) but not p38 and ERK1/2, and SP600125 (an inhibitor of JNK) almost reversed icariin-induced apoptosis in SMMC-7721 cells. In addition, icariin provoked the generation of reactive oxygen species (ROS) in SMMC-7721 cells, while the antioxidant N-acetyl cysteine almost completely blocked icariin-induced JNK activation and apoptosis. Taken together, these findings suggest that icariin induces apoptosis through a ROS/JNK-dependent mitochondrial pathway.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674153     DOI: 10.1016/j.canlet.2010.07.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  42 in total

Review 1.  Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: From bench to bedside.

Authors:  Bing Hu; Shuang-Shuang Wang; Qin Du
Journal:  World J Hepatol       Date:  2015-05-28

2.  2',4'-Dihydroxy-6'-methoxy-3',5'-dimethylchalcone, from buds of Cleistocalyx operculatus, induces apoptosis in human hepatoma SMMC-7721 cells through a reactive oxygen species-dependent mechanism.

Authors:  Chun-Lin Ye; Yi-Feng Lai
Journal:  Cytotechnology       Date:  2014-09-27       Impact factor: 2.058

3.  Fisetin inhibits the growth and migration in the A549 human lung cancer cell line via the ERK1/2 pathway.

Authors:  Junjian Wang; Shaoxiang Huang
Journal:  Exp Ther Med       Date:  2017-12-21       Impact factor: 2.447

4.  Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB.

Authors:  Dian-cai Zhang; Jin-long Liu; Yong-bin Ding; Jian-guo Xia; Guo-yu Chen
Journal:  Acta Pharmacol Sin       Date:  2012-12-31       Impact factor: 6.150

5.  Fine particle matters induce DNA damage and G2/M cell cycle arrest in human bronchial epithelial BEAS-2B cells.

Authors:  Jing Wu; Yanfeng Shi; Collins Otieno Asweto; Lin Feng; Xiaozhe Yang; Yannan Zhang; Hejing Hu; Junchao Duan; Zhiwei Sun
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-18       Impact factor: 4.223

6.  Protective effects of 7-difluoromethyl-5,4'-dimethoxygenistein against human aorta endothelial injury caused by lysophosphatidyl choline.

Authors:  Fei Liu; Jian-Guo Cao; Cheng Li; Jin-Seng Tan; Xiao-Hua Fu
Journal:  Mol Cell Biochem       Date:  2011-12-24       Impact factor: 3.396

7.  Current update on anticancer effects of icariin: A journey of the last ten years.

Authors:  Mukta Gupta; Yachana Mishra; Vijay Mishra; Murtaza M Tambuwala
Journal:  EXCLI J       Date:  2022-04-06       Impact factor: 4.022

Review 8.  Phytoconstituents as apoptosis inducing agents: strategy to combat cancer.

Authors:  Manish Kumar; Varinder Kaur; Subodh Kumar; Satwinderjeet Kaur
Journal:  Cytotechnology       Date:  2015-08-04       Impact factor: 2.058

9.  Wentilactone B induces G2/M phase arrest and apoptosis via the Ras/Raf/MAPK signaling pathway in human hepatoma SMMC-7721 cells.

Authors:  Z Zhang; L Miao; C Lv; H Sun; S Wei; B Wang; C Huang; B Jiao
Journal:  Cell Death Dis       Date:  2013-06-06       Impact factor: 8.469

10.  Icariin Prevents Amyloid Beta-Induced Apoptosis via the PI3K/Akt Pathway in PC-12 Cells.

Authors:  Dongdong Zhang; Zhe Wang; Chenxia Sheng; Weijun Peng; Shan Hui; Wei Gong; Shuai Chen
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.